Cells maintain the balance between homeostasis and inflammation by adapting and 22 integrating the activity of intracellular signalling cascades, including the JAK-STAT pathway.
144
3b). To avoid overexpression artefacts, we matched IRF9-BirA* with endogenous IRF9 145 levels ( Supplementary Fig. 3c ) and used cells expressing an N-terminally myc tagged BirA* 146 gene as controls. We examined STAT-IRF9 proximity prior to IFN treatment by parallel 147 reaction monitoring (PRM), an approach allowing to specifically acquire information about 148 peptides of interest and their quantities 23 . PRM revealed that IRF9-BirA* biotinylated both 149 itself and STAT2 in two biological replicates ( Fig. 4a, Supplementary table 2) . In contrast, between IRF9 and a number of chromatin modifiers ( Fig. 4b-d ; Supplementary Fig. 4a ).
156
To rule out that the lack of interaction between IRF9 and STAT1 resulted from the 7 unavailability of lysines for biotinylation, we generated Raw 264.7 macrophages expressing 158 a Dox-inducible, myc-tagged STAT2-BirA* fusion gene. STAT2-BirA* expressed at 159 endogenous levels was functional and restored the IFN response of Stat2-/-MEFs 160 ( Supplementary Fig. 3d, e ). PRM confirmed IRF9 proximity to STAT2-BirA* and additionally 161 revealed proximity between STAT2 and STAT1 (Fig. 4e ). The latter finding was further 162 verified in western blots of STAT2-BirA*cell lysates with HRP-coupled streptavidin 163 ( Supplementary Fig. 3e ). Treatment with IFN further increased the interaction between 164 STAT2 and IRF9 ( Supplementary Fig. 4b ). Importantly, the spectrum of STAT2 interactors 165 partially overlapped with that produced in the IRF9-BioID approach (Fig. 4b 
175
(lanes 5 and 6) and results from nonspecific association to the carrier material). This 176 behaviour resembles complex binding in ChIP-Seq ( Fig. 2 ). We conclude that ISRE binding 177 either stabilizes ISGF3 or is required for its formation.
179
Signalling requirements for STAT2-IRF9 formation
180
The revving-up model of innate immunity predicts that the molecular machinery for 181 constitutive ISG expression requires a low chronic signal from the IFN receptor. It further 182 implies that a small quantity of ISGF3 subunits should be nuclear in untreated cells. To test 183 these assumptions, we first analysed the cellular localization of ISGF3 subunits. We have 8 recently shown that IFN-induced nuclear localization of STAT2 is reduced in Irf9-/-BMDMs 185 24 . It follows that a portion of IRF9 should be localized to the cell nucleus and that nuclear 186 shuttling of at least a sub-fraction of STAT2 requires IRF9. Indeed, the majority of IRF9 in 187 resting cells was found in the nucleus by immunofluorescence and IFN-I treatment did not 188 further enhance nuclear accumulation ( Fig. 5a ). Raw 264.7 cell fractionation and western 189 blots revealed that nuclei from resting cells contained IRF9 and a small fraction of STAT2,
190
but not STAT1 (Fig. 5b ). The small quantity of STAT1 bound to chromatin according to
191
ChIP-Seq appears to be below the detection limit. To assess whether IFN receptor signalling 
233

Discussion
234
Recent findings suggest that unphosphorylated STAT complexes control ISG expression 8 .
235
Our study shows an important contribution of STAT2-IRF9 complexes, formed independently priming cells for enhanced cytokine responsiveness, this homeostatic mechanism reveals its 258 importance in the maintenance and mobilization of the hematopoietic stem cell niche 29, 30 .
259
More recent studies suggest that multipotent stem cells achieve ISG expression and an 260 antiviral state independently of IFNAR signalling 31 . The results strengthen the idea that 261 mobilization of ISG promoters via STATs can be uncoupled from IFN-I receptor signalling.
262
The uSTAT model provided a first proof of principle for this possibility. Accordingly, the 263 prolongation of ISG expression occurs via formation of a uISGF3 complex following an early,
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IFNAR-dependent response that increases the levels of ISGF3 subunits 9 . In hepatic cells a . This revealed a large overlap with genes whose expression was impaired by the loss of 272 IRF9 in our study. Importantly, tonic-sensitive loci showed higher STAT2 binding at baseline Funding was provided by the Austrian Science Fund (FWF) through grants P 25186-B22,
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